Results 131 to 140 of about 8,893,093 (256)

Qianjinweijingtang Decoction and Its Granule Inhibit Respiratory Syncytial Virus Infection and the Associated Inflammatory Response

open access: yesChemistry &Biodiversity, Volume 23, Issue 9, September 2026.
The classical herbal formula Qianjinweijingtang in both decoction and granule forms, exhibits anti‐RSV activity. Isoliquiritigenin, quercetin, and gallic acid are identified as key active compounds. The mechanism involves interfering with viral entry and downregulating HIF‐1α and inflammatory responses, positioning the granule formulation as a ...
Chu‐Yi Liao   +11 more
wiley   +1 more source

Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level

open access: yesEmerging Infectious Diseases, 2022
Ian G. Barr   +3 more
doaj   +1 more source

Human Respiratory Syncytial Virus and Human Metapneumovirus

open access: yes, 2009
The human respiratory syncytial virus (hRSV) and the human metapneumovírus (hMPV) are main etiological agents of acute respiratory infections (ARI). The ARI is an important cause of childhood morbidity and mortality worldwide.  hRSV and hMPV are members of the Paramyxoviridae.
da Silva, Luciana Helena Antoniassi   +4 more
openaire   +1 more source

Coxsackievirus B Infections Are Associated With the Risk of Islet Autoimmunity in Children With Strong Genetic Susceptibility to Type 1 Diabetes—Results From the TRIGR Divia Study

open access: yesDiabetes/Metabolism Research and Reviews, Volume 42, Issue 6, September 2026.
ABSTRACT Aims Especially, the coxsackievirus B group of enteroviruses has been linked to the development of islet autoimmunity and type 1 diabetes in genetically susceptible individuals. Our aim was to study the possible associations of 10 different microbial infections with islet autoimmunity in a large international prospective study.
Maarit Oikarinen   +14 more
wiley   +1 more source

Multiplexed detection of eight respiratory viruses based on nanozyme colorimetric microfluidic immunoassay

open access: yesFrontiers in Bioengineering and Biotechnology
Pandemics caused by respiratory viruses, such as the SARS-CoV-1/2, influenza virus, and respiratory syncytial virus, have resulted in serious consequences to humans and a large number of deaths.
Feng Wu   +8 more
doaj   +1 more source

Human Metapneumovirus and Its Association With Otorhinolaryngological Manifestations: A Systematic Review With Descriptive Synthesis

open access: yesEye &ENT Research, Volume 3, Issue 3, Page 111-117, September 2026.
ABSTRACT Human metapneumovirus (HMPV) is a respiratory virus that predominantly affects the pediatric population. Its role as an infective agent in ear, nose, and throat (ENT) diseases is not yet well understood. To systematically review the available literature on the association between HMPV and ENT manifestations, following PRISMA guidelines, a ...
Ali Gohar   +12 more
wiley   +1 more source

A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein. [PDF]

open access: yesAntimicrob Agents Chemother, 2020
DeVincenzo J   +11 more
europepmc   +1 more source

B‐Cell Remodeling and Regulatory Phenotypes During Acute COVID‐19 Are Unaffected by Polyclonal Anti‐SARS‐CoV‐2 Antibody XAV‐19

open access: yesEuropean Journal of Immunology, Volume 56, Issue 9, September 2026.
SARS‐CoV‐2 infection drives transient B‐cell remodeling toward an activated, regulatory‐like phenotype. In this randomized sub‐study, the polyclonal neutralizing antibody XAV‐19 did not detectably alter B‐cell phenotype, transcriptome, or function relative to placebo, indicating that passive polyclonal therapy preserves B‐cell homeostasis during acute ...
Nicolas Degauque   +19 more
wiley   +1 more source

Risk of admission requirement among children with respiratory infection in the post-COVID-19 pandemic era

open access: yesJournal of Infection and Public Health
Background: To evaluate the effect of the type and codetection of respiratory viruses on admission requirements among children with respiratory infections in the post-COVID-19 pandemic era.
Takahiro Mori   +14 more
doaj   +1 more source

Causes and Contributing Factors of In‐Hospital and Post‐Discharge Mortality Among Patients With Severe Acute Respiratory Infection in Low‐ and Middle‐Income Countries: A Scoping Review

open access: yesHealth Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Severe acute respiratory infections (SARI) remain a major cause of global morbidity and mortality, with a disproportionate burden in low‐ and middle‐income countries (LMICs). Although in‐hospital mortality is frequently reported, deaths occurring after hospital discharge remain poorly documented.
Md Ariful Islam   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy